دورية أكاديمية

Adipocyte Metrnl Antagonizes Insulin Resistance Through PPARγ Signaling.

التفاصيل البيبلوغرافية
العنوان: Adipocyte Metrnl Antagonizes Insulin Resistance Through PPARγ Signaling.
المؤلفون: Zhi-Yong Li, Jie Song, Si-Li Zheng, Mao-Bing Fan, Yun-Feng Guan, Yi Qu, Jian Xu, Pei Wang, Chao-Yu Miao, Li, Zhi-Yong, Song, Jie, Zheng, Si-Li, Fan, Mao-Bing, Guan, Yun-Feng, Qu, Yi, Xu, Jian, Wang, Pei, Miao, Chao-Yu
المصدر: Diabetes; Dec2015, Vol. 64 Issue 12, p4011-4022, 12p, 8 Graphs
مصطلحات موضوعية: FAT cells, INSULIN resistance, ADIPOKINES, HOMEOSTASIS, WHITE adipose tissue, GENETIC overexpression, AUTOCRINE mechanisms, PARACRINE mechanisms, PROTEIN metabolism, ADIPOSE tissues, ANIMAL experimentation, HUMAN body composition, CELL physiology, CELLS, CELLULAR signal transduction, COMPARATIVE studies, DIET, GENES, GENETIC techniques, RESEARCH methodology, MEDICAL cooperation, MICE, NERVE growth factor, PEPTIDE hormones, PROTEINS, RECOMBINANT proteins, RESEARCH, RODENTS, LEPTIN, EVALUATION research, BODY mass index, CHEMICAL inhibitors
مستخلص: Adipokines play important roles in metabolic homeostasis and disease. We have recently identified a novel adipokine Metrnl, also known as Subfatin, for its high expression in subcutaneous fat. Here, we demonstrate a prodifferentiation action of Metrnl in white adipocytes. Adipocyte-specific knockout of Metrnl exacerbates insulin resistance induced by high-fat diet (HFD), whereas adipocyte-specific transgenic overexpression of Metrnl prevents insulin resistance induced by HFD or leptin deletion. Body weight and adipose content are not changed by adipocyte Metrnl. Consistently, no correlation is found between serum Metrnl level and BMI in humans. Metrnl promotes white adipocyte differentiation, expandability, and lipid metabolism and inhibits adipose inflammation to form functional fat, which contributes to its activity against insulin resistance. The insulin sensitization of Metrnl is blocked by PPARγ inhibitors or knockdown. However, Metrnl does not drive white adipose browning. Acute intravenous injection of recombinant Metrnl has no hypoglycemic effect, and 1-week intravenous administration of Metrnl is unable to rescue insulin resistance exacerbated by adipocyte Metrnl deficiency. Our results suggest adipocyte Metrnl controls insulin sensitivity at least via its local autocrine/paracrine action through the PPARγ pathway. Adipocyte Metrnl is an inherent insulin sensitizer and may become a therapeutic target for insulin resistance. [ABSTRACT FROM AUTHOR]
Copyright of Diabetes is the property of American Diabetes Association and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:00121797
DOI:10.2337/db15-0274